Haemonetics Corp. (HAE)
79.00
+0.29
(+0.37%)
USD |
NYSE |
Jun 10, 16:00
78.87
-0.13
(-0.16%)
After-Hours: 19:16
Haemonetics Enterprise Value : 4.591B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 4.591B |
| June 08, 2026 | 4.418B |
| June 05, 2026 | 4.255B |
| June 04, 2026 | 4.190B |
| June 03, 2026 | 4.011B |
| June 02, 2026 | 4.033B |
| June 01, 2026 | 4.071B |
| May 29, 2026 | 4.098B |
| May 28, 2026 | 4.063B |
| May 27, 2026 | 4.068B |
| May 26, 2026 | 4.054B |
| May 22, 2026 | 3.993B |
| May 21, 2026 | 3.832B |
| May 20, 2026 | 3.725B |
| May 19, 2026 | 3.602B |
| May 18, 2026 | 3.621B |
| May 15, 2026 | 3.577B |
| May 14, 2026 | 3.614B |
| May 13, 2026 | 3.609B |
| May 12, 2026 | 3.473B |
| May 11, 2026 | 3.393B |
| May 08, 2026 | 3.524B |
| May 07, 2026 | 3.490B |
| May 06, 2026 | 3.413B |
| May 05, 2026 | 3.546B |
| Date | Value |
|---|---|
| May 04, 2026 | 3.533B |
| May 01, 2026 | 3.711B |
| April 30, 2026 | 3.749B |
| April 29, 2026 | 3.700B |
| April 28, 2026 | 3.737B |
| April 27, 2026 | 3.766B |
| April 24, 2026 | 3.741B |
| April 23, 2026 | 3.727B |
| April 22, 2026 | 3.796B |
| April 21, 2026 | 3.754B |
| April 20, 2026 | 3.797B |
| April 17, 2026 | 3.818B |
| April 16, 2026 | 3.749B |
| April 15, 2026 | 3.833B |
| April 14, 2026 | 3.766B |
| April 13, 2026 | 3.711B |
| April 10, 2026 | 3.623B |
| April 09, 2026 | 3.673B |
| April 08, 2026 | 3.723B |
| April 07, 2026 | 3.725B |
| April 06, 2026 | 3.675B |
| April 02, 2026 | 3.601B |
| April 01, 2026 | 3.574B |
| March 31, 2026 | 3.580B |
| March 30, 2026 | 3.434B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Integra LifeSciences Holdings Corp. | 3.167B |
| Boston Scientific Corp. | 82.51B |
| QuidelOrtho Corp. | 3.684B |
| Globus Medical, Inc. | 10.68B |
| Abbott Laboratories | 186.33B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.15M |
| Revenue (Quarterly) | 346.35M |
| Total Expenses (Quarterly) | 366.50M |
| EPS Diluted (Quarterly) | -0.4359 |
| Gross Profit Margin (Quarterly) | 54.21% |
| Profit Margin (Quarterly) | -5.82% |
| Earnings Yield | 2.57% |
| Operating Earnings Yield | 6.52% |
| Normalized Earnings Yield | 4.276 |